Skip to main content

Finding Compounds in Databases using UniChem




Have you ever identified an interesting compound and wondered what else is known about it?  For example is there any bioactivity data on it in ChEMBL or PubChem?  Is there any toxicity data on it (CompTox)?  Then having found interesting data on a compound wondered if it can be purchased or whether it has been patented.  All this can be done using UniChem.  Interested?  

Come along to our webinar on 29th March at 2pm BST (3pm CEST, 9am EDT)
You will however need to register by emailing chembl-help. Places are limited so please let us know as soon as possible if you register but are then unable to attend.

If you want to know more about UniChem please read on.

UniChem (https://www.ebi.ac.uk/unichem/  is a simple system we have developed to cross-reference compounds across databases both internal to EMBL-EBI and externally. Currently we have cross-references to 140 million compounds in 30 different databases. Information about the sources indexed in UniChem can be found here. UniChem is updated weekly with new compounds from these source databases.

So, for example, you can input a database identifier or an InChIKey into UniChem and see links to all the other indexed databases that have information about that compound.

If we take the drug paroxetine and search for it in UniChem, it is found in 22 databases and the UniChem webpage gives links to the paroxetine entries in those databases.

You don’t have to do this compound by compound using the web interface though.  UniChem has a comprehensive set of  web services that you can use to retrieve data or alternatively all the database files and source to source mapping files are available for download.

UniChem relies on the InChIKey to do the mapping between databases and this works fine if two databases have exactly the same structure for a compound.  We all know however that this isn’t always the case.  Sometimes a different salt or isotope was tested or a mistake was made in the stereocentre assignment meaning the InChIKeys no longer match.

However don’t despair.  UniChem connectivity searching can help. https://www.ebi.ac.uk/unichem/info/widesearchInfo  It turns out that because of the clever way that the InChI is built up with layers, this can be deconstructed and mapping can be done such that the relationship between compounds that differ by stereochemistry, isotopes, protonation state etc can all be identified and mapped. You can do this on single components or mixtures.

Taking our paroxetine example:

We have paroxetine and a number of related compounds in ChEMBL. For example:
Maybe someone wanted to genuinely test these related compounds or maybe they are errors (or a mixture of both).  Whatever the reason by using the UniChem connectivity searching feature we can identify any compounds that match paroxetine on the InChI connectivity layer.
The matches identified from a connectivity search starting with paroxetine can be found here:

At the webinar on 29th March we will describe how this is done in more detail and discuss some use cases.  If you are interested don’t forget to register.

If you want to read more here are links to two papers about UniChem:
Chambers, J., Davies, M., Gaulton, A., Hersey, A., Velankar, S., Petryszak, R., Hastings, J., Bellis, L., McGlinchey, S. and Overington, J.P. 
UniChem: A Unified Chemical Structure Cross-Referencing and Identifier Tracking System.
Journal of Cheminformatics2013, 5:3 (January 2013).


Chambers, J., Davies, M., Gaulton, A., Papadatos, G., Hersey and Overington, J.P.
UniChem: extension of InChI-based compound mapping to salt, connectivity and stereochemistry layers.
Journal of Cheminformatics2014, 6:43 (September 2014)

Comments

Popular posts from this blog

ChEMBL 34 is out!

We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. This version of the database, prepared on 28/03/2024 contains:         2,431,025 compounds (of which 2,409,270 have mol files)         3,106,257 compound records (non-unique compounds)         20,772,701 activities         1,644,390 assays         15,598 targets         89,892 documents Data can be downloaded from the ChEMBL FTP site:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/ Please see ChEMBL_34 release notes for full details of all changes in this release:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/chembl_34_release_notes.txt New Data Sources European Medicines Agency (src_id = 66): European Medicines Agency's data correspond to EMA drugs prior to 20 January 2023 (excluding vaccines). 71 out of the 882 newly added EMA drugs are only authorised by EMA, rather than from other regulatory bodies e.g.

New SureChEMBL announcement

(Generated with DALL-E 3 ∙ 30 October 2023 at 1:48 pm) We have some very exciting news to report: the new SureChEMBL is now available! Hooray! What is SureChEMBL, you may ask. Good question! In our portfolio of chemical biology services, alongside our established database of bioactivity data for drug-like molecules ChEMBL , our dictionary of annotated small molecule entities ChEBI , and our compound cross-referencing system UniChem , we also deliver a database of annotated patents! Almost 10 years ago , EMBL-EBI acquired the SureChem system of chemically annotated patents and made this freely accessible in the public domain as SureChEMBL. Since then, our team has continued to maintain and deliver SureChEMBL. However, this has become increasingly challenging due to the complexities of the underlying codebase. We were awarded a Wellcome Trust grant in 2021 to completely overhaul SureChEMBL, with a new UI, backend infrastructure, and new f

Accessing SureChEMBL data in bulk

It is the peak of the summer (at least in this hemisphere) and many of our readers/users will be on holiday, perhaps on an island enjoying the sea. Luckily, for the rest of us there is still the 'sea' of SureChEMBL data that awaits to be enjoyed and explored for hidden 'treasures' (let me know if I pushed this analogy too far). See here and  here for a reminder of SureChEMBL is and what it does.  This wealth of (big) data can be accessed via the SureChEMBL interface , where users can submit quite sophisticated and granular queries by combining: i) Lucene fields against full-text and bibliographic metadata and ii) advanced structure query features against the annotated compound corpus. Examples of such queries will be the topic of a future post. Once the search results are back, users can browse through and export the chemistry from the patent(s) of interest. In addition to this functionality, we've been receiving user requests for  local (behind the

New Drug Approvals - Pt. XVII - Telavancin (Vibativ)

The latest new drug approval, on 11th September 2009 was Telavancin - which was approved for the treatment of adults with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria , including Staphylococcus aureus , both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains. Telavancin is also active against Streptococcus pyogenes , Streptococcus agalactiae , Streptococcus anginosus group (includes S. anginosus, S. intermedius and S. constellatus ) and Enterococcus faecalis (vancomycin susceptible isolates only). Telavancin is a semisynthetic derivative of Vancomycin. Vancomycin itself is a natural product drug, isolated originally from soil samples in Borneo, and is produced by controlled fermentation of Amycolatopsis orientalis - a member of the Actinobacteria . Telavancin has a dual mechanism of action, firstly it inhibits bacterial cell wall synthesis by interfering with the polymerization and cross-linking of peptid

A python client for accessing ChEMBL web services

Motivation The CheMBL Web Services provide simple reliable programmatic access to the data stored in ChEMBL database. RESTful API approaches are quite easy to master in most languages but still require writing a few lines of code. Additionally, it can be a challenging task to write a nontrivial application using REST without any examples. These factors were the motivation for us to write a small client library for accessing web services from Python. Why Python? We choose this language because Python has become extremely popular (and still growing in use) in scientific applications; there are several Open Source chemical toolkits available in this language, and so the wealth of ChEMBL resources and functionality of those toolkits can be easily combined. Moreover, Python is a very web-friendly language and we wanted to show how easy complex resource acquisition can be expressed in Python. Reinventing the wheel? There are already some libraries providing access to ChEMBL d